Back

Engineering genetic resilience for cardiometabolic HFpEF: the crucial role of redox homeostasis

17 May 2025 (08:00 - 12:45)
Organised by: Logo
Congress Presentation Part of: Young Investigator Award (YIA) Basic Science Heart Failure HFA Premium Access Heart Failure 2025 Heart Failure Association (HFA)

About the speaker

Photo
Doctor Mark Pepin

Stanford University School of Medicine, Stanford (United States of America)

3 More presentations in this session

Presentation thumbnail
Dapagliflozin in primary prevention of cardiotoxicity induced by anthracycline-trastuzumab therapy through activation of pAMPK and inhibition of MyD88 and NLRP-3
Doctor V. Quagliariello (Naples, IT)
Abstract Slides Video
Presentation thumbnail
Phospholamban antisense therapy reduces phospholamban aggregation and enhances calcium and contractile kinetics in human phospholamban cardiomyopathy
Mr F. Deiman (Groningen, NL)
Abstract Slides Video
Presentation thumbnail
A multifactorial porcine model of cardio-metabolic HFpEF highlights miR-483-3p as a promising target therapy
Miss K. Kohlat (German Heart Center Of Charite Berlin, DE)
Abstract Slides Video

Access the full session

Session thumbnail
Young Investigator Award (YIA) Basic Science
Video

The Event

Event poster

Heart Failure 2025

17 May - 20 May 2025
You may be interested in
thumbnail
Congress Session
Heart failure in the era of precision medicine: insights into pathophysiology and emerging treatments
thumbnail
Congress Presentation
Adverse chromatin remodelling by SETD7 drives inflammation and diastolic dysfunction in obese heart failure with preserved ejection fraction
thumbnail
Congress Session
Biomarkers in the era of 'OMICS': potential beyond diagnosis

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources